Our previous studies[13, 14] showed that the baseline plasma level of insulin-like growth factor-1 (IGF-1) was significantly associated with degree of CLD, HCC characteristics and patients’ OS duration. This evidence concerns the gene IGF1 and hepatocellular carcinoma.